Taking into account that inositol pathway dysregulation, through IP6 treatment, inhibits mTOR pathway activation and the metabolic adaptation mediated by the signature in G4 MB cells, we set out to assess their impact on tumour cell viability. Here, MTOR is linked to neoplasm.